Wall Street Zen downgraded shares of SBC Medical Group (NASDAQ:SBC – Free Report) from a strong-buy rating to a buy rating in a research report report published on Saturday,Wall Street Zen reports.
Several other equities analysts also recently weighed in on SBC. BTIG Research reiterated a “buy” rating and set a $8.00 target price on shares of SBC Medical Group in a research report on Thursday, August 13th. Weiss Ratings upgraded SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 9th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $8.00.
View Our Latest Report on SBC Medical Group
SBC Medical Group Stock Performance
Shares of SBC Medical Group stock traded up $2.01 on Friday, hitting $7.35. 1,710,244 shares of the company’s stock were exchanged, compared to its average volume of 190,995. The company has a 50-day simple moving average of $5.13 and a 200-day simple moving average of $3.98. The stock has a market capitalization of $755.95 million, a PE ratio of 15.64, a PEG ratio of 2.40 and a beta of 0.52. SBC Medical Group has a 1 year low of $2.78 and a 1 year high of $7.39. The company has a debt-to-equity ratio of 0.09, a quick ratio of 3.27 and a current ratio of 3.31.
SBC Medical Group (NASDAQ:SBC – Get Free Report) last issued its quarterly earnings data on Friday, November 13th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.03. The firm had revenue of $58.58 million during the quarter, compared to the consensus estimate of $48.90 million. SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. As a group, equities analysts anticipate that SBC Medical Group will post 0.44 EPS for the current year.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. BlackRock Inc. bought a new stake in SBC Medical Group during the second quarter valued at about $2,846,000. Citadel Advisors LLC bought a new position in shares of SBC Medical Group in the second quarter worth about $446,000. Russell Investments Group Ltd. boosted its stake in shares of SBC Medical Group by 2,810.4% in the third quarter. Russell Investments Group Ltd. now owns 125,991 shares of the company’s stock worth $622,000 after acquiring an additional 121,662 shares during the period. Marshall Wace LLP bought a new position in shares of SBC Medical Group in the third quarter worth about $520,000. Finally, Segall Bryant & Hamill LLC purchased a new stake in shares of SBC Medical Group during the first quarter worth about $340,000. Hedge funds and other institutional investors own 60.82% of the company’s stock.
Latest SBC Medical Group News
Here’s some of the latest news about SBC:
- Positive Sentiment: Third-quarter revenue rose 35% to $58.6 million, ahead of the $48.9 million analyst estimate. EPS of $0.15 also beat the $0.12 consensus. Net income attributable to SBC increased 22% to $15.7 million, while adjusted EBITDA rose 66% year over year. SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results
- Positive Sentiment: Growth was supported by higher management-services revenue, service-fee revisions and the consolidation of Waqoo. The clinic network expanded to 293 locations, up 36 from a year earlier; the company reported $198.4 million in cash at quarter-end. SBC Medical Q3 Revenue Rises 35% to $58.6 Million
- Positive Sentiment: SBC announced a capital and business alliance with NeuroBrain Dynamics, a generative-AI company, with the stated goal of using medical AI to improve clinic profitability. The financial impact and rollout details were not disclosed. SBC Medical Announces Capital and Business Alliance with NeuroBrain Dynamics
About SBC Medical Group
SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care. The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.
Further Reading
- Five stocks we like better than SBC Medical Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
